Last news
Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

Teva Prolia® (Denosumab) Biosimilar Candidate is Accepted for Review by U.S. FDA and EU EMA

...

ORBCOMM joins Move to -15°C coalition to promote cold chain sustainability

ORBCOMM joins Move to -15°C coalition to promote cold chain sustainability

...

Mavenir 5G Core Powers ice Norway Network Slicing for Norwegian Armed Forces

Mavenir 5G Core Powers ice Norway Network Slicing for Norwegian Armed Forces

...

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

Boehringer receives U.S. FDA Breakthrough Therapy designation and initiates two phase III trials in MASH for survodutide

...

Nasdaq Launches PureStream in Europe – A new tool for trajectory trading

Nasdaq Launches PureStream in Europe – A new tool for trajectory trading

...

2ONE Labs and Performance Plus Marketing, sellers of 2ONE Nicotine Pouches, Allege Fraud and Seek Damages in 'Zone' Trademark Infringement Case Against Imperial Brands

2ONE Labs and Performance Plus Marketing, sellers of 2ONE Nicotine Pouches, Allege Fraud and Seek Damages in 'Zone' Trademark Infringement Case Against Imperial Brands

...

FDH Aero Announces New Contract Agreement for COMAC C919 Platform

FDH Aero Announces New Contract Agreement for COMAC C919 Platform

...

Nyxoah Raises $27 Million through its At-the-Market Offering

Nyxoah Raises $27 Million through its At-the-Market Offering

...

1 ... 72 73 74 75 76 77 78 79 80 ... 707
menu
menu